human collagen 7
Recombinant proteinexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 9, 2019 (NCT03752905)
Timeline
Indications
Studied for
Mechanism of action
- Collagen alpha-1(VII) chainSupplementation
COL7A1 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05143190 | Phase 2 | Nov 25, 2021 | Bridge BioResearch Ltd., Phoenix Tissue Repair, Inc. |
| NCT04599881 | Phase 2 | Oct 15, 2020 | Phoenix Tissue Repair, Inc. |
| NCT03752905 | Phase 1/Phase 2 (Phase 2) | Jan 9, 2019 | Phoenix Tissue Repair, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Phoenix Tissue Repair, Inc. | For profit | 3 | 3 | 1 | 2019 |
| Bridge BioResearch Ltd. | For profit | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1